Document:

<PAGE>   1

                                                                  EXHIBIT 10.19

                        COURSEWARE DEVELOPMENT AGREEMENT

         This Courseware Development Agreement ("Agreement"), is entered into as
of January __, 2000 ("Effective Date") between e-Vitro, Inc., a Colorado
corporation, with its principal place of business at 507 Canyon Boulevard, Suite
200, Boulder, Colorado 80302 ("Developer") and HealthStream, Inc., a Tennessee
corporation, with its principal place of business at 209 10th Avenue South,
Suite 450, Nashville, Tennessee 37203 ("HealthStream").

         WHEREAS, HealthStream wishes to engage the services of Developer to
develop browser-based interactive training modules;

         WHEREAS, HealthStream and Developer wish to provide appropriate
consideration for those efforts that each party has agreed to undertake;

         WHEREAS, as part of the consideration for those efforts, Developer and
HealthStream have agreed to enter into a certain Warrant to Purchase Common
Stock of Developer of even date herewith (the "Warrant");

         WHEREAS, HealthStream and Developer each acknowledge the sufficiency
and adequacy of the value, concessions, and recitations set forth herein;

         NOW THEREFORE, HealthStream and Developer agree as follows:

SECTION 1. DEFINITIONS. As used in this Agreement, the following terms shall
have the meanings assigned below:

         A. "Content" shall mean the material and knowledge components to be
contributed by HealthStream and other entities as determined by HealthStream
("HealthStream's Content Partners") necessary for the development of the
modules. Content includes the procedural sequences, standard operating
procedures, photographs, videos, instruction manuals and screen images supplied
by HealthStream and HealthStream's Content Partners to Developer for
incorporation into the modules defined hereafter.

         B. "Interactive Content" shall mean Developer's computer browser-based
adaptation and implementation of the Content for delivery through HealthStream's
Training Navigator(R) (or T.NAV(R)) System.

         C. "Modules" shall mean Interactive Content that has been organized
into a clearly defined and limited course of study equaling no fewer than one
hundred twenty (120) browser-based screens. Modules may be comprised of
disparate Content subjects equaling no fewer than one hundred twenty (120)
browser-based screens. Subject to Developer's reservation of rights as specified
in Section 3.1 herein, Modules are the proprietary property of HealthStream.

SECTION 2. COURSEWARE DEVELOPMENT

     2.1 Courseware Development.

         A.       Developer hereby agrees to develop Interactive Content into no
                  fewer than forty (40) Modules or a combination of browser
                  screens that would equal forty (40) Modules according to the
                  Quality Criterion outlined in Section 2.1.B below,
                  (collectively, the "Courseware").

<PAGE>   2

         B.       Developer agrees to develop all Courseware at a level of
                  quality and interactivity substantially equal to or greater
                  than those courses developed by HealthStream for the Cleveland
                  Clinic Foundation. Developer also agrees to develop the
                  Courseware so that it may function and work with
                  HealthStream's T.NAV System. Such criterion for the Courseware
                  shall be known as the "Quality Criterion." HealthStream shall
                  not be obligated to pay for any Courseware unless HealthStream
                  reasonably believes the Quality Criterion has been satisfied.

         C.       Developer agrees to develop Content into Courseware and
                  deliver completed Courseware to HealthStream no later than
                  sixty (60) days following receipt of the Content from
                  HealthStream.

         D.       Both parties will ensure that resources from both parties will
                  be allocated to accomplish the development of the Courseware
                  in a timely fashion. Developer shall provide HealthStream with
                  a weekly status update of the development of the Courseware.

         E.       The Modules will be developed in "Alpha" and "Beta" test
                  phases (each, a "Phase"). Upon completion of a Phase,
                  Developer shall provide notice to this effect to
                  HealthStream (the "Completion Notice"). Within ten (10) days
                  after the receipt of the Completion Notice by HealthStream;
                  Developer and HealthStream shall consult and cooperate with
                  each other to determine whether the subject Module
                  substantially conforms with the applicable Quality Criterion
                  at such Phase. In the event HealthStream determines in its
                  reasonable discretion that the Module does not substantially
                  conform with the applicable Quality Criterion, HealthStream
                  shall provide written notice to Developer within such ten
                  (10) day period containing a description of the failure to
                  conform (the "Defect Notice"). Within twenty (20) days after
                  its receipt of the Defect Notice, Developer shall make such
                  corrections or modifications as may be necessary for the
                  subject Module to substantially conform with the applicable
                  Quality Criterion. Within ten (10) days after the date the
                  corrections or modifications are made, HealthStream shall in
                  its reasonable discretion make a determination about whether
                  such corrected or modified Module substantially conforms
                  with the applicable Quality Criterion. In the event
                  HealthStream determines such corrected or modified Module
                  substantially conforms with the applicable Quality
                  Criterion, HealthStream shall provide written notice of
                  acceptance of the Module. In the event such corrected or
                  modified Module does not substantially conform with the
                  applicable Quality Criterion, the procedure for correction
                  and modification provided for in this Subsection shall be
                  repeated until such time as the Module substantially
                  conforms with the applicable Quality Criterion. In the event
                  HealthStream fails to deliver a Defect Notice to Developer
                  within the period specified in this Subsection, HealthStream
                  shall be deemed to have made acceptance of such Module.

         2.2. Courseware Development Fee. Upon execution of this Agreement,
HealthStream shall pay to Developer Ninety Five Thousand and No/100ths Dollars
(US$95,000). Upon delivery to HealthStream of a completed Module and upon
HealthStream's reasonable determination that the Module satisfies the Quality
Criterion, HealthStream shall pay to Developer Ten Thousand and No/100ths
Dollars (US$10,000.00) per completed Module. HealthStream is responsible for any
and all taxes, other than income, applicable to or in connection with the
services rendered by Developer.

         2.3. Expenses. Upon the submission of invoices by Developer,
HealthStream shall reimburse Developer for reasonable travel, room, and board
expenses incurred by Developer in connection with its performance of the
services provided for in this Agreement.

                                       2.
<PAGE>   3

SECTION 3. INTELLECTUAL PROPERTY OWNERSHIP.

         3.1. HealthStream's Retained Rights. The Courseware is a "work made for
hire," and Developer's work on the Courseware has been specially ordered by
HealthStream and will be developed under HealthStream's direction and control.
Developer's work on the Courseware is derivative of HealthStream's previous work
and merely a contribution to HealthStream's collective work. HealthStream is the
sole author of the Courseware, its contents, and any work embodying or derived
from any portion of the Courseware. HealthStream is also the owner of the
Courseware and all intellectual property rights related to the Courseware, and
to the extent that the Courseware is not properly characterized as "work made
for hire," or to the extent that Developer has rendered any Courseware design
services on behalf of HealthStream prior to the date of this Agreement, then
Developer will irrevocably grant, assign, and otherwise transfer, and hereby
does irrevocably grant, assign, and transfer, exclusively and in perpetuity to
HealthStream, its successors and its assigns, all intellectual property rights
and other rights of Developer in the Courseware whatsoever, now existing or
hereafter discovered, in all media and forms of expression. The provisions of
this Section shall not have application to any methods, processes, technology,
approaches, know-how, development tools, or third-party software (with respect
to which Developer is unable to make a transfer) which are used in connection
with, or incorporated in, the Courseware, and all of the foregoing, together
with any proprietary rights associated with any of the foregoing, shall be
exclusively owned by the Developer.

         3.2. Reproduction, Derivation, Performance and Display Rights.
Developer grants, assigns and otherwise transfers exclusively and in perpetuity
to HealthStream, its successors and its assigns, any right Developer may have to
reproduce, make derivative works, publicly perform or publicly display the
Courseware, and the right to license or sublicense the Courseware, or any
portion thereof; provided, however, subject to section 4.2 herein, HealthStream
acknowledges and agrees that Developer may without restriction develop,
distribute, and use computer software and courseware that is similar to the
Courseware and has the same intended functionality as the Courseware, regardless
of whether such computer software or courseware is competitive with the
Courseware or provided to competitors of HealthStream.

SECTION 4. CONFIDENTIAL AND PROPRIETARY INFORMATION.

         4.1. Confidentiality. HealthStream and Developer acknowledge that they
have been and will be in a confidential relationship with each other, and that
they have each gained and will gain knowledge that comprises valuable trade
secrets and other confidential information of the other party (collectively, the
"Confidential Information"), which is the exclusive property of the other party,
including, without limitation, customer data, sales and marketing data and
strategies, technical information, and data concerning financial and educational
institutions. Each party agrees that it will not disclose any of the other
party's Confidential Information, nor will either party take any action that
might reasonably be expected to lead to such disclosure, both during the term of
this Agreement and thereafter. Each party agrees that it will not use any of the
other party's Confidential Information, nor will either party take any action
that might reasonably be expected to lead to such use, both during the term of
this Agreement and thereafter, except for the purposes of this Agreement.

         4.2. Non-Competition. Developer agrees that, during the term of this
Agreement and for a period of one (1) year following termination or expiration
of this Agreement, Developer shall not design or develop, or render design or
development services to third parties with respect to any products having
subject matter that is so similar to the Modules or Courseware developed
pursuant to the terms of this Agreement that such product would directly compete
with the Modules or the Courseware. Because HealthStream's business is
accessible on the worldwide web, Developer agrees that this non-competition
provision will apply worldwide, and that this worldwide scope is reasonable.

         4.3. Specific Performance. Developer acknowledges and agrees that the
performance of the obligations under this Section 4 is special, unique and
extraordinary in character. In addition to such other rights and remedies that
HealthStream may have at equity or law with respect to any breach by Developer
of any of the provisions of this Section 4, HealthStream shall have the right
and remedy to have such

                                       3.

<PAGE>   4

provisions specifically enforced by any court of competent jurisdiction or to
enjoin Developer from performing any act taken by Developer in violation of this
Section 4. Developer acknowledges and agrees that any such breach or threatened
breach will cause irreparable injury to HealthStream and its business and that
money damages will not provide an adequate remedy to HealthStream.

                                       4.
<PAGE>   5

SECTION 5. WARRANTIES AND REPRESENTATIONS

        A.    Developer warrants and represents that:

              A.   All of the services Developer performs under this Agreement
                   will be performed in a professional and workmanlike manner,
                   consistent with generally accepted industry standards, using
                   properly trained personnel.

              B.   Developer has all requisite power, authority and legal right
                   to execute, deliver and perform its obligations under this
                   Agreement and all of such actions have been duly and validly
                   authorized by all necessary proceedings on the part of
                   Developer.

              C.   No authorization, consent, approval, license, permit,
                   exemption or other action by, and no registration,
                   qualification, designation, declaration or filing with any
                   governmental authority is or will be necessary in connection
                   with the execution of this Agreement.

              D.   Developer will substantially comply with all applicable laws
                   and regulations in the performance of its obligations under
                   this Agreement

              E.   The execution and delivery of this Agreement by Developer
                   does not and will not: (a) materially violate any applicable
                   law; or (b) conflict with or result in a material breach of
                   or default under any agreement or instrument to which
                   Developer is a party or by which any of its properties is
                   bound.

              F.   There is no pending action, suit or threatened proceeding by
                   or before any governmental authority against Developer that
                   in any way affects Developer's ability to enter into this
                   Agreement or perform any of Developer's obligations
                   hereunder.

              G.   To the best of Developer's knowledge, and as applicable,
                   ability, Developer's work shall not (a) impair or infringe
                   on the intellectual property rights of any third party or
                   any rights of publicity or privacy; (b) violate any law,
                   including without limitation, the laws and regulations
                   governing export control, unfair competition,
                   antidiscrimination or false advertising; (c) be defamatory,
                   trade libelous, or unlawfully harassing; (d) be obscene,
                   child pornographic or indecent; (e) contain any viruses,
                   trojan horses, trap doors, easter eggs, worms, time bombs,
                   or other computer programming routines intended to damage,
                   interfere with, intercept, or expropriate any system, date
                   or business/personal information.

              H.   To the best of Developer's ability, The Courseware shall be
                   free of any bugs or programming devices that are designed to
                   disrupt or are capable of disrupting the use or
                   functionality of T.NAV.

              I.   The Courseware shall perform substantially as described
                   herein.

              J.   THE DEVELOPER EXPRESSLY DISCLAIMS ANY AND ALL IMPLIED
                   WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY IMPLIED
                   WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR
                   PURPOSE, OR ACCURACY OF INFORMATIONAL CONTENT.

        B.    HealthStream warrants and represents that:

              1.   HealthStream has all requisite power, authority and legal
                   right to execute, deliver and perform its obligations under
                   this Agreement and all of such actions have

                                       5.
<PAGE>   6

                   been duly and validly authorized by all necessary
                   proceedings on the part of HealthStream.

              2.   The execution and delivery of this Agreement by HealthStream
                   does not and will not: (a) materially violate any applicable
                   law; or (b) conflict with or result in a material breach of
                   or default under any agreement or instrument to which
                   HealthStream is a party or by which any of its properties is
                   bound.

              3.   The Content shall not infringe any patents, copyrights,
                   trade secrets, or other proprietary rights of any third
                   parties, and HealthStream will have no reason to believe
                   that any such infringement or claims thereof could be made
                   by third parties.

SECTION 6.    TERM AND TERMINATION.

        6.1.  Term. This Agreement shall be effective as of the date hereof and
shall continue, unless sooner terminated as provided herein, for twelve (12)
months.

        6.2.  Termination. This Agreement may be terminated upon the occurrence
of one or more of the following events:

         A.   HealthStream may terminate this Agreement without cause upon
              sixty (60) days prior written notice to Developer. Upon receipt
              of such notice, Developer shall inform HealthStream of the extent
              to which performance has been completed through such date or
              receipt of notice, and collect and deliver to HealthStream all
              work product and any Courseware then existing in a manner
              prescribed by HealthStream. Developer shall be paid for all work
              performed through the date of receipt of notice of such
              termination;

         B.   Either party may terminate this Agreement if the other party
              seeks protection under the bankruptcy laws (other than as a
              creditor) or any assignment is made for the benefit of creditors
              or a trustee is appointed for all or any portion of such party's
              assets;

         C.   Either party may terminate this Agreement if the other party is
              in default of any material provision of this Agreement and such
              default is not cured within thirty (30) days after receipt of
              written notice of default by such other party.

        6.3   Post-Termination Rights.

         A.   Upon termination of this Agreement, each party shall immediately
              deliver to the other party all copies of the other party's
              Confidential Information in such party's possession or control;
              and Developer shall immediately deliver to HealthStream (a) all
              Courseware, including any Modules, Content, and Interactive
              Content; and (b) any other information or item related to this
              Agreement in Developer's possession or control.

         B.   If this Agreement is terminated for any reason, subject to
              Developer's reservation of rights as specified in Section 3.1
              herein, Developer will and hereby does grant to HealthStream all
              right, title, and interest, including all United States and
              international copyrights and all other intellectual property
              rights in the Courseware.

SECTION 7. INDEMNITIES AND INSURANCE.

         Developer agrees to:

                                       6.
<PAGE>   7

         A.   Indemnify and hold harmless HealthStream from any liability
              resulting from the actions of any officer, director, employee or
              agent of Developer in the performance of this Agreement,
              including any and all losses, claims penalties, expenses,
              actions, suits, obligations, damages, liabilities, and liens (and
              all costs and expenses, including reasonable attorney's fees
              incurred in connection therewith), that HealthStream sustains or
              incurs or may sustain or incur in connection with Developer's
              performance hereunder, or as a consequence of any default by
              Developer in the performance or observance of any covenant or
              condition contained in this Agreement, including without
              limitation, the breach of any representation or warranty, the
              failure of Developer to substantially comply with any of
              HealthStream's specifications for its Courseware, or the failure
              to substantially comply with any applicable requirements of law
              (the "Claims"). Developer agrees that upon written notice by
              HealthStream of the assertion of any Claims, Developer shall, at
              HealthStream's option, either assume full responsibility for, or
              reimburse HealthStream for the reasonable costs and expenses of,
              the defense thereof.

         B.   Obtain and maintain during the term of this Agreement all
              insurance coverage reasonably necessary to guard against all
              risks of loss that may arise out of, or relating to, this
              Agreement, including business interruption insurance.

         HealthStream agrees to:

         A.   Indemnify and hold harmless Developer from and against any and
              all claims that the Content or any portion thereof, infringes
              upon any patent, copyright, trade secret, or other proprietary
              rights.

         B.   Indemnify and hold harmless Developer from and against any and
              all claims or liability arising out of or related to the use,
              results of the use or the application of Courseware specifically
              relating to Content provided by HealthStream.

SECTION 8. MISCELLANEOUS.

         8.1 Further Actions. Developer agrees to take any future actions that
HealthStream may reasonably deem necessary or advisable to implement the terms
of this Agreement.

         8.2. No Implied Waivers. No action or course of dealing on the part of
either party, their officers, employees, consultants, or agents, nor any failure
or delay by either party with respect to exercising any right, power or
privilege of such party under this Agreement shall operate as a waiver thereof,
except to the extent expressly provided therein.

         8.3. Attorneys' Fees, Costs and Expenses. Each party agrees to pay all
reasonable costs and expenses, including, without limitation, attorney's fees
and compensation for time spent by the other party's employees, that either
party may incur in enforcing the terms of this Agreement against the other
party, in protecting such party's rights hereunder, or in amending, waiving or
modifying any of the terms hereunder.

         8.4. Limitation on Damages. Neither party shall have liability to the
other party or any other person or organization for, and each party expressly
waives, all remedies and damages relating to indirect, incidental, and
consequential or special damages of any description, whether arising out of
warranty or other contract, negligence or other tort, or otherwise, including
without limitation, recession, difference in value damages, capital losses,
foreseeable business losses, loss of profits, and reliance damages. Under no
circumstances shall the Developer's liability under this Agreement for any cause
exceed the amount paid by HealthStream to the Developer; and under no
circumstances shall HealthStream's liability under this Agreement for any cause
exceed an amount equal to One Hundred

                                       7.
<PAGE>   8

Thousand and No/100ths Dollars (US$100,000), plus Ten Thousand and No/100ths
Dollars (US$10,000) multiplied by the number of Modules delivered by the
Developer to HealthStream.

         8.5. Notices. All notices shall be deemed received three days after
they are sent by certified mail, return receipt requested, or when actually
received by hand-delivery or overnight courier. All notices shall be sent to:

To HealthStream:       Robert Laird, Esq.
                       General Counsel/Vice President of Finance
                       HealthStream, Inc.
                       209 10th Avenue South, Suite 450
                       Nashville, TN 37203

To Developer:          Mark L. Schroeder
                       Chief Executive Officer
                       E-Vitro, Inc.
                       507 Canyon Boulevard
                       Suite 200
                       Boulder, Colorado  80302

         8.6. Headings. Captions and headings to sections are included
solely for convenience and are not intended to affect the interpretation of any
provision of this Agreement.

         8.7. Force Majeure. In the event an act of the government, war
conditions, fire, flood, or other act of God prevents either party from
performing in accordance with the provisions of this Agreement, such
nonperformance shall be excused and shall not be considered a breach or default
for so long as the said conditions prevail.

         8.8. Independent Contractors. Each party to this Agreement is an
independent contractor and this Agreement shall not be construed as creating a
joint venture, partnership, agency or employment relationship between the
parties hereto nor shall either party have the right, power or authority to
create any obligation or duty, express or implied, on behalf of the other.
Developer shall be fully responsible for paying all income taxes, penalties and
interest, in addition to workers compensation and Social Security wages of any
personnel under the employ of Developer, if any, and the filing of all necessary
documents, forms and returns pertinent to all of the foregoing.

         8.9. Preferred Vendor Status. Developer may represent that HealthStream
is a preferred vendor of Developer in any of its marketing materials; provided,
however that upon prior written notice by HealthStream of its desire to
terminate such preferred vendor status, Developer agrees to (1) cease and desist
including any such representation or reference to HealthStream in its marketing
materials; and (2) cease and desist using or distributing any marketing
materials that may contain such representation or reference to HealthStream.

         8.10. Assignment. This Agreement shall be binding upon and inure to the
benefit of HealthStream and Developer and their respective successors and
assigns; provided, however, HealthStream has retained Developer for Developer's
unique development capabilities and Developer shall not delegate any of its
duties under this Agreement to any other person or entity without the prior
written consent of HealthStream, which consent shall not be unreasonably
withheld.

         8.11. Governing Law. This Agreement shall be governed by the laws of
the State of Tennessee without regard to its choice of law provisions.

         8.12. Severability. The invalidity or unenforceability of any of the
provisions of this Agreement shall not affect the validity of the rest of this
Agreement. Each provision of this Agreement shall be

                                       8.

<PAGE>   9

enforceable to the fullest extent permitted by law. If a court finds that any
provision of this Agreement is invalid or unenforceable, but that by limiting
such provision it would become valid and enforceable, then such provision shall
be deemed to be written, construed, and enforced as so limited.

         8.13. Entire Agreement. This Agreement is the entire agreement between
the parties related to the matters herein and replaces and supersedes all other
agreements, proposals, and understandings, oral or written. This Agreement may
be amended only in writing and must be signed by appropriate officers of the
parties hereto.

         8.14. Counterparts. This Agreement may be executed in any number of
counterparts, each of which, when so executed, shall be deemed an original, but
all such counterparts shall constitute but one and the same instrument.

         IN WITNESS WHEREOF, and intending to be legally bound hereby, each
party hereto warrants and represents that this Agreement has been duly
authorized by all necessary corporate action and that this agreement has been
duly executed by and constitutes a valid and binding agreement of that party.
All signed copies of this Agreement shall be deemed originals.

                                      HealthStream, Inc.

                                      By:
                                         ----------------------------

                                      Title:
                                             ------------------------

                                      Date:
                                            -------------------------

                                      e-Vitro, Inc.

                                      By:
                                         ----------------------------

                                      Title:
                                            -------------------------

                                      Date:
                                           --------------------------

                                       9.<PAGE>   1

                                                                    EXHIBIT 10.1

                     ---------------------------------------

                            STAR SERVICES GROUP, INC.
                             1999 STOCK OPTION PLAN

                     ---------------------------------------

         1. PURPOSE. The purpose of this Plan is to advance the interests of
STAR SERVICES GROUP, INC., a Florida corporation (the "Company"), and its
Subsidiaries by providing an additional incentive to attract and retain
qualified and competent persons who provide management services and upon whose
efforts and judgment the success of the Company and its Subsidiaries is largely
dependent, through the encouragement of stock ownership in the Company by such
persons.

         2. DEFINITIONS. As used herein, the following terms shall have the
meaning indicated:

                  (a) "Board" shall mean the Board of Directors of the Company.

                  (b) "Code" shall mean the Internal Revenue Code of 1986, as
amended from time to time.

                  (c) "Committee" shall mean the committee appointed by the
Board pursuant to Section 13(a) hereof, or, if such committee is not appointed,
the Board.

                  (d) "Common Stock" shall mean the Company's Common Stock, par
value $0.01 per share, or any shares of common stock into which the Company's
Common Stock may be converted pursuant to any reorganization, merger or
consolidation that does not result in the cancellation or termination of Options
under the Plan pursuant to Section 9(b) or 10(c) hereof.

                  (e) "Company" shall mean STAR SERVICES GROUP, INC., a Florida
corporation.

                  (f) "Director" shall mean a member of the Board.

                  (g) "Effective Date" shall mean February 3, 1999.

                  (h) "Fair Market Value" of a Share on any date of reference
shall mean the fair market value of a Share of the Company's Common Stock on
that date, as determined by the Committee in a fair and uniform manner. If the
Company's Common Stock is Publicly-Held, then Fair Market Value shall mean the
"Closing Price" (as defined below) of the Common Stock on the business day
immediately preceding the date of reference, unless the Committee in its sole
discretion shall determine otherwise in a fair and uniform manner. For the
purpose of determining Fair Market Value, the "Closing Price" of the Common
Stock on any business day shall be (i) if the Common Stock is listed or admitted
for trading on any United States national securities exchange, or if actual
transactions are otherwise reported on a consolidated transaction reporting
system, the last reported sale price of Common Stock on such exchange or
reporting system, as reported in any newspaper of general circulation, (ii) if
the Common Stock is quoted on the National Association of Securities Dealers
Automated Quotations System ("NASDAQ"), or any similar system of automated
dissemination of quotations of securities prices in common use, the last
reported sale price of Common Stock on such system or, if sales prices are not
reported, the mean between the closing high bid and low asked quotations for
such day of Common Stock on such system, as reported in any newspaper of general
circulation or (iii) if neither clause (i) or (ii) is applicable, the mean
between the high bid and low asked quotations for the Common Stock as reported
by the National Quotation Bureau, Incorporated if at least two securities
dealers have inserted both bid and asked quotations for Common Stock on at least
five of the ten preceding days.

<PAGE>   2

                  (i) "Incentive Stock Option" shall mean an incentive stock
option as defined in Section 422 of the Internal Revenue Code.

                  (j) "Internal Revenue Code" shall mean the Internal Revenue
Code of 1986, as amended from time to time.

                  (k) "Non-Qualified Stock Option" shall mean an Option that is
not an Incentive Stock Option.

                  (l) "Officer" shall mean the Company's Chairman of the Board,
President, Chief Executive Officer, principal financial officer, principal
accounting officer, any vice-president of the Company in charge of a principal
business unit, division or function (such as sales, administration or finance),
any other officer who performs a policy-making function, or any other person who
performs similar policy-making functions for the Company. Officers of
Subsidiaries shall be deemed Officers of the Company if they perform such
policy-making functions for the Company. As used in this paragraph, the phrase
"policy-making function" does not include policy-making functions that are not
significant. If pursuant to Item 401(b) of Regulation S-K (17 C.F.R. ss.
229.401(b)) the Company identifies a person as an "executive officer," the
person so identified shall be deemed an "Officer" even though such person may
not otherwise be an "Officer" pursuant to the foregoing provisions of this
paragraph.

                  (m) "Option" (when capitalized) shall mean any option granted
under this Plan.

                  (n) "Option Agreement" means the agreement between the Company
and the Optionee for the grant of an option.

                  (o) "Optionee" shall mean a person to whom a stock option is
granted under this Plan or any person who succeeds to the rights of such person
under this Plan by reason of the death of such person.

                  (p) "Outside Director" shall mean a member of the Board who
qualifies as an "outside director" under Section 162(m) of the Internal Revenue
Code and the regulations thereunder and as a "Non-Employee Director" under Rule
16b-3 promulgated under the Securities Exchange Act.

                  (q) "Plan" shall mean this Stock Option Plan for the Company.

                  (r) "Publicly-Traded", when applied to the Shares, shall mean
that the Shares are registered under the Securities Exchange Act of 1934, as
amended.

                  (s) "Securities Exchange Act" shall mean the Securities
Exchange Act of 1934, as amended.

                  (t) "Share" shall mean a share of Common Stock.

                  (u) "Subsidiary" shall mean any corporation (other than the
Company) in any unbroken chain of corporations beginning with the Company if, at
the time of the granting of the Option, each of the corporations other than the
last corporation in the unbroken chain owns stock possessing 50 percent or more
of the total combined voting power of all classes of stock in one of the other
corporations in such chain.

         3. SHARES AVAILABLE FOR OPTION GRANTS. The Committee or the Board may
grant to Optionees from time to time Options to purchase an aggregate of up to
Five Million (5,000,000) Shares from the Company's authorized and unissued
Shares. If any Option granted under the Plan shall terminate, expire,

                                       2
<PAGE>   3

or be canceled or surrendered as to any Shares, new Options may thereafter be
granted covering such Shares.

         4. INCENTIVE AND NON-QUALIFIED OPTIONS.

                  (a) An Option granted hereunder shall be either an Incentive
Stock Option or a Non-Qualified Stock Option as determined by the Committee or
the Board at the time of grant of such Option and shall clearly state whether it
is an Incentive Stock Option or Non-Qualified Stock Option. All Incentive Stock
Options shall be granted within 10 years from the effective date of this Plan.
Incentive Stock Options may not be granted to any person who is not an employee
of the Company or any Subsidiary.

                  (b) Options otherwise qualifying as Incentive Stock Options
hereunder will not be treated as Incentive Stock Options to the extent that the
aggregate fair market value (determined at the time the Option is granted) of
the Shares, with respect to which Options meeting the requirements of Section
422(b) of the Code are exercisable for the first time by any individual during
any calendar year (under all plans of the Company and its parent and subsidiary
corporations as defined in Section 424 of the Code), exceeds $100,000.

         5. CONDITIONS FOR GRANT OF OPTIONS.

                  (a) Each Option shall be evidenced by an option agreement that
may contain any term deemed necessary or desirable by the Committee or the
Board, provided such terms are not inconsistent with this Plan or any applicable
law. Optionees shall be (i) those persons selected by the Committee or the Board
from the class of all regular employees of, or persons who provide consulting or
other services as independent contractors to, the Company or its Subsidiaries,
including Directors and Officers who are regular employees, and (ii) Directors
who are not employees of the Company or of any Subsidiaries. Any person who
files with the Committee, in a form satisfactory to the Committee, a written
waiver of eligibility to receive any Option under this Plan shall not be
eligible to receive any Option under this Plan for the duration of such waiver.

                  (b) In granting Options, the Committee or the Board shall take
into consideration the contribution the person has made to the success of the
Company or its Subsidiaries and such other factors as the Committee shall
determine. The Committee or the Board shall also have the authority to consult
with and receive recommendations from officers and other personnel of the
Company and its Subsidiaries with regard to these matters. The Committee or the
Board may from time to time in granting Options under the Plan prescribe such
other terms and conditions concerning such Options as it deems appropriate,
including, without limitation, (i) prescribing the date or dates on which the
Option becomes exercisable, (ii) providing that the Option rights accrue or
become exercisable in installments over a period of years, or upon the
attainment of stated goals or both, or (iii) relating an Option to the continued
employment of the Optionee for a specified period of time, provided that such
terms and conditions are not more favorable to an Optionee than those expressly
permitted herein.

                  (c) The Options granted to employees under this Plan shall be
in addition to regular salaries, pension, life insurance or other benefits
related to their employment with the Company or its Subsidiaries. Neither the
Plan nor any Option granted under the Plan shall confer upon any person any
right to employment or continuance of employment by the Company or its
Subsidiaries.

                  (d) Notwithstanding any other provision of this Plan, an
Incentive Stock Option shall not be granted to any person owning directly or
indirectly (through attribution under Section 424(d) of the Code) at the date of
grant, stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company (or of its parent or subsidiary [as defined in
Section 424 of the Code] at the date of grant) unless the option price of such
Option is at least 110% of the Fair Market Value of the Shares subject to such
Option on the date the Option is granted, and such Option by its terms is not
exercisable after the expiration of five years from the date such Option is
granted.

                                       3
<PAGE>   4

                  (e) Notwithstanding any other provision of this Plan, and in
addition to any other requirements of this Plan, the aggregate number of Options
granted to any one Optionee may not exceed One Million (1,000,000) subject to
adjustment as provided in Section 10 hereof.

         6. OPTION PRICE. The option price per Share of any Option shall be any
price determined by the Committee but shall not be less than the par value per
Share; provided, however, that in no event shall the option price per Share of
any Incentive Stock Option be less than the Fair Market Value of the Shares
underlying such Option on the date such Option is granted.

         7. EXERCISE OF OPTIONS. An Option shall be deemed exercised when (i)
the Company has received written notice of such exercise in accordance with the
terms of the Option, (ii) full payment of the aggregate option price of the
Shares as to which the Option is exercised has been made, and (iii) arrangements
that are satisfactory to the Committee in its sole discretion have been made for
the Optionee's payment to the Company of the amount that is necessary for the
Company or Subsidiary employing the Optionee to withhold in accordance with
applicable Federal or state tax withholding requirements. The consideration to
be paid for the Shares to be issued upon exercise of an Option, including the
method of payment, shall be determined by the Committee or the Board (and in the
case of an Incentive Stock Option, shall be determined at the time of the grant)
and may consist of: (1) cash, (2) certified or official bank check, (3) money
order, (4) Shares that have been held by the Optionee for at least six (6)
months (or such other Shares as the Company determines will not cause the
Company to realize a financial accounting charge), (5) the withholding of Shares
issuable upon exercise of the Option, (6) by delivery of a properly executed
exercise notice together with such other documentation, and subject to such
guidelines, as the Board or the Committee and the broker, if applicable, shall
require to effect an exercise of the Option and delivery to the Company of the
sale or loan proceeds required to pay the exercise price and any applicable
income or employment taxes, or (7) in such other consideration as the Committee
or the Board deems appropriate, or by a combination of the above. In the case of
an Incentive Stock Option, the permissible forms of payment shall be established
by the Committee or the Board at the time the Option is granted. The Committee
or the Board in its sole discretion may accept a personal check in full or
partial payment of any Shares. If the exercise price is paid in whole or in part
with Shares, or through the withholding of Shares issuable upon exercise of the
Option, the value of the Shares surrendered or withheld shall be their Fair
Market Value on the date the Option is exercised. The Company in its sole
discretion may, on an individual basis or pursuant to a general program
established in connection with this Plan, lend money to an Optionee, guarantee a
loan to an Optionee, or otherwise assist an Optionee to obtain the cash
necessary to exercise all or a portion of an Option granted hereunder or to pay
any tax liability of the Optionee attributable to such exercise. If the exercise
price is paid in whole or part with Optionee's promissory note, such note shall
(i) provide for full recourse to the maker, (ii) be collateralized by the pledge
of the Shares that the Optionee purchases upon exercise of such Option, (iii)
bear interest at the prime rate of the Company's principal lender, and (iv)
contain such other terms as the Board in its sole discretion shall reasonably
require. No Optionee shall be deemed to be a holder of any Shares subject to an
Option unless and until a stock certificate or certificates for such Shares are
issued to such person(s) under the terms of this Plan. No adjustment shall be
made for dividends (ordinary or extraordinary, whether in cash, securities or
other property) or distributions or other rights for which the record date is
prior to the date such stock certificate is issued, except as expressly provided
in Section 10 hereof.

         8. EXERCISABILITY OF OPTIONS. Any Option shall be exercisable (i) as to
25% of the Shares subject to the Option on the first anniversary of the date on
which such option is granted (the "Grant Date"); (ii) as to an additional 25% of
the Shares subject to the Option on the second anniversary of the Grant Date;
(iii) as to an additional 25% of the Shares subject to the Option on the third
anniversary of the Grant Date and (iv) as to an additional 25% of the Shares
subject to the Option on the fourth anniversary of the Grant Date.

                                       4
<PAGE>   5

                  (a) The expiration date of an Option shall be determined by
the Committee at the time of grant, but in no event shall an Option be
exercisable after the expiration of 10 years from the date of grant of the
Option.

                  (b) The Committee or the Board may in its sole discretion
accelerate the date on which any Option may be exercised and may accelerate the
vesting of any Shares subject to any Option or previously acquired by the
exercise of any Option.

         9. TERMINATION OF OPTION PERIOD.

                  (a) Unless otherwise provided in any Agreement, the
unexercised portion of any Option shall automatically and without notice
terminate and become null and void at the time of the earliest to occur of the
following:

                           (i) unless otherwise provided in any Option, three
months after the date on which the Optionee's employment is terminated other
than by reason of (A) Cause, which, solely for purposes of this Plan, shall mean
the termination of the Optionee's employment by reason of the Optionee's willful
misconduct or gross negligence, (B) a mental or physical disability (within the
meaning of Internal Revenue Code Section 22(e)) of the Optionee as determined by
a medical doctor satisfactory to the Committee, or (C) death of the Optionee;

                           (ii) immediately upon the termination of the
Optionee's employment for Cause;

                           (iii) twelve months after the date on which the
Optionee's employment is terminated by reason of a mental or physical disability
(within the meaning of Section 22(e) of the Code) as determined by a medical
doctor satisfactory to the Committee;

                           (iv) (A) twelve months after the date of termination
of the Optionee's employment by reason of death of the employee, or, if later,
(B) three months after the date on which the Optionee shall die if such death
shall occur during the one year period specified in Subsection 9(a)(iii) hereof;
or

                           (v) immediately in the event that the Optionee shall
file any lawsuit or arbitration claim against the Company or any Subsidiary, or
any of their respective officers, directors or shareholders.

                  (b) To the extent not previously exercised, (i) each Option
shall terminate immediately in the event of (1) the liquidation or dissolution
of the Company, or (2) any reorganization, merger, consolidation or other form
of corporate transaction in which the Company does not survive, unless the
successor corporation, or a parent or subsidiary of such successor corporation,
assumes the Option or substitutes an equivalent option or right pursuant to
Section 10(c) hereof, and (ii) the Committee or the Board in its sole discretion
may by written notice ("cancellation notice") cancel, effective upon the
consummation of any corporate transaction described in Subsection 8(c)(i) hereof
in which the Company does survive, any Option that remains unexercised on such
date. The Committee or the Board shall give written notice of any proposed
transaction referred to in this Section 9(b) a reasonable period of time prior
to the closing date for such transaction (which notice may be given either
before or after approval of such transaction), in order that Optionees may have
a reasonable period of time prior to the closing date of such transaction within
which to exercise any Options that then are exercisable (including any Options
that may become exercisable upon the closing date of such transaction). An
Optionee may condition his exercise of any Option upon the consummation of a
transaction referred to in this Section 9(b).

                                       5
<PAGE>   6

         10. ADJUSTMENT OF SHARES.

                  (a) If at any time while the Plan is in effect or unexercised
Options are outstanding, there shall be any increase or decrease in the number
of issued and outstanding Shares through the declaration of a stock dividend or
through any recapitalization resulting in a stock split-up, combination or
exchange of Shares, then and in such event:

                           (i) appropriate adjustment shall be made in the
maximum number of Shares available for grant under the Plan, so that the same
percentage of the Company's issued and outstanding Shares shall continue to be
subject to being so optioned; and

                           (ii) appropriate adjustment shall be made in the
number of Shares and the exercise price per Share thereof then subject to any
outstanding Option, so that the same percentage of the Company's issued and
outstanding Shares shall remain subject to purchase at the same aggregate
exercise price.

                  (b) Unless otherwise provided in any Option, the Committee may
change the terms of Options outstanding under this Plan, with respect to the
option price or the number of Shares subject to the Options, or both, when, in
the Committee's sole discretion, such adjustments become appropriate by reason
of a corporate transaction described in Subsections 8(c)(ii) or (iii) hereof so
as to preserve but not increase benefits under the Plan.

                  (c) In the event of a proposed sale of all or substantially
all of the Company's assets or any reorganization, merger, consolidation or
other form of corporate transaction in which the Company does not survive, where
the securities of the successor corporation, or its parent company, are issued
to the Company's shareholders, then the successor corporation or a parent of the
successor corporation may, with the consent of the Committee or the Board,
assume each outstanding Option or substitute an equivalent option or right. If
the successor corporation, or its parent, does not cause such an assumption or
substitution to occur, or the Committee or the Board does not consent to such an
assumption or substitution, then each Option shall terminate pursuant to Section
9(b) hereof upon the consummation of sale, merger, consolidation or other
corporate transaction.

                  (d) Except as otherwise expressly provided herein, the
issuance by the Company of shares of its capital stock of any class, or
securities convertible into shares of capital stock of any class, either in
connection with direct sale or upon the exercise of rights or warrants to
subscribe therefor, or upon conversion of shares or obligations of the Company
convertible into such shares or other securities, shall not affect, and no
adjustment by reason thereof shall be made to, the number of or exercise price
for Shares then subject to outstanding Options granted under the Plan.

                  (e) Without limiting the generality of the foregoing, the
existence of outstanding Options granted under the Plan shall not affect in any
manner the right or power of the Company to make, authorize or consummate (i)
any or all adjustments, recapitalizations, reorganizations or other changes in
the Company's capital structure or its business; (ii) any merger or
consolidation of the Company; (iii) any issue by the Company of debt securities,
or preferred or preference stock that would rank above the Shares subject to
outstanding Options; (iv) the dissolution or liquidation of the Company; (v) any
sale, transfer or assignment of all or any part of the assets or business of the
Company; or (vi) any other corporate act or proceeding, whether of a similar
character or otherwise.

         11. TRANSFERABILITY OF OPTIONS AND SHARES. Each Option shall provide
that such Option shall not be transferable by the Optionee otherwise than by
will or the laws of descent and distribution, and each Option shall be
exercisable during the Optionee's lifetime only by the Optionee.

                                       6
<PAGE>   7

         12. ISSUANCE OF SHARES.

                  (a) Notwithstanding any other provision of this Plan, the
Company shall not be obligated to issue any Shares unless it is advised by
counsel of its selection that it may do so without violation of the applicable
Federal and State laws pertaining to the issuance of securities, and may require
any stock so issued to bear a legend, may give its transfer agent instructions,
and may take such other steps, as in its judgment are reasonably required to
prevent any such violation.

                  (b) As a condition to any sale or issuance of Shares upon
exercise of any Option, the Committee may require such agreements or
undertakings as the Committee may deem necessary or advisable to facilitate
compliance with any applicable law or regulation including, but not limited to,
the following:

                           (i) a representation and warranty by the Optionee to
the Company, at the time any Option is exercised, that he is acquiring the
Shares to be issued to him for investment and not with a view to, or for sale in
connection with, the distribution of any such Shares; and

                           (ii) a representation, warranty and/or agreement to
be bound by any legends endorsed upon the certificate(s) for such Shares that
are, in the opinion of the Committee, necessary or appropriate to facilitate
compliance with the provisions of any securities laws deemed by the Committee to
be applicable to the issuance and transfer of such Shares.

         13. ADMINISTRATION OF THE PLAN.

                  (a) The Plan shall be administered by the Board or, at the
discretion of the Board, by a committee appointed by the Board (the "Committee")
which shall be composed of two or more Directors. At any time that any shares of
the Common Stock of the Company shall be registered under Section 12 of the
Securities Exchange Act of 1934, the membership of the Committee shall be
constituted so as to comply at all times with the then applicable requirements
for Outside Directors of Rule 16b-3 promulgated under the Securities Exchange
Act and Section 162(m) of the Internal Revenue Code. The Committee shall serve
at the pleasure of the Board and shall have the powers designated herein and
such other powers as the Board may from time to time confer upon it.

                  (b) The Board may grant Options pursuant to this Plan to any
persons to whom Options may be granted under Section 5(a) hereof.

                  (c) The Committee or the Board, from time to time, may adopt
rules and regulations for carrying out the purposes of the Plan. The Committee's
determinations and its interpretation and construction of any provision of the
Plan or any Option shall be final and conclusive.

                  (d) Any and all decisions or determinations of the Committee
shall be made either (i) by a majority vote of the members of the Committee at a
meeting or (ii) without a meeting by the unanimous written approval of the
members of the Committee.

         14. WITHHOLDING OR DEDUCTION FOR TAXES. If at any time specified herein
for the making of any issuance or delivery of any Option or Common Stock to any
Optionee, any law or regulation of any governmental authority having
jurisdiction in the premises shall require the Company to withhold, or to make
any deduction for, any taxes or take any other action in connection with the
issuance or delivery then to be made, such issuance or delivery shall be
deferred until such withholding or deduction shall have been provided for by the
Optionee or beneficiary, or other appropriate action shall have been taken.

                                       7
<PAGE>   8

         15. INTERPRETATION.

                  (a) As it is the intent of the Company that the Plan comply in
all respects with Rule 16b-3 promulgated under the Securities Exchange Act
("Rule 16b-3"), any ambiguities or inconsistencies in construction of the Plan
shall be interpreted to give effect to such intention, and if any provision of
the Plan is found not to be in compliance with Rule 16b-3, such provision shall
be deemed null and void to the extent required to permit the Plan to comply with
Rule 16b-3. The Committee or the Board may from time to time adopt rules and
regulations under, and amend, the Plan in furtherance of the intent of the
foregoing.

                  (b) The Plan shall be administered and interpreted so that all
Incentive Stock Options granted under the Plan will qualify as Incentive Stock
Options under Section 422 of the Code. If any provision of the Plan should be
held invalid for the granting of Incentive Stock Options or illegal for any
reason, such determination shall not affect the remaining provisions hereof, but
instead the Plan shall be construed and enforced as if such provision had never
been included in the Plan.

                  (c) This Plan shall be governed by the laws of the State of
Florida.

                  (d) Headings contained in this Plan are for convenience only
and shall in no manner be construed as part of this Plan.

                  (e) Any reference to the masculine, feminine, or neuter gender
shall be a reference to such other gender as is appropriate.

         16. AMENDMENT AND DISCONTINUATION OF THE PLAN. The Committee or the
Board may from time to time amend, suspend or terminate the Plan or any Option;
provided, however, that, any amendment to the Plan shall be subject to the
approval of the Company's shareholders if such shareholder approval is required
by any federal or state law or regulation (including, without limitation, Rule
16b-3 or to comply with Section 162(m) of the Internal Revenue Code) or the
rules of any Stock exchange or automated quotation system on which the Common
Stock may then be listed or granted. Except to the extent provided in Sections 9
and 10 hereof, no amendment, suspension or termination of the Plan or any Option
issued hereunder shall substantially impair the rights or benefits of any
Optionee pursuant to any Option previously granted without the consent of the
Optionee.

         17. EFFECTIVE DATE AND TERMINATION DATE. The effective date of the Plan
is the date on which the Board adopts this Plan, and the Plan shall terminate on
the 10th anniversary of the Effective Date.

                                       8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]